These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 384672)

  • 1. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of zinc in renal diseases.
    Alam SM; Gupta A; Kumar S; Sikka KK; Srivastava DK
    J Indian Med Assoc; 1986 Aug; 84(8):233-6. PubMed ID: 3559228
    [No Abstract]   [Full Text] [Related]  

  • 5. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation and renal diseases.
    Kanfer A
    Proc Eur Dial Transplant Assoc; 1983; 19():703-13. PubMed ID: 6348762
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protein supply in healthy subjects and subjects with kidney diseases].
    Gerhardt W
    Z Arztl Fortbild (Jena); 1969 Mar; 63(6):317-22. PubMed ID: 5784072
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of formation and diagnostic value of fibrin fibrinogen split products in kidney allotransplantation].
    Drannik GN
    Urol Nefrol (Mosk); 1979; (2):62-9. PubMed ID: 375530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical problems in cadaver kidney transplantation. 135 transplants in 128 patients].
    Ringoir S
    Verh K Acad Geneeskd Belg; 1978; 40(3):149-83. PubMed ID: 364869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta2-microglobulin--immunological and nephrological aspects (review of the literature)].
    Galaĭ BM
    Vrach Delo; 1984 Mar; (3):76-80. PubMed ID: 6372245
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 19. [Excretion of the fibrin-fibrinogen degradation products as a sign of rejection of transplanted kidney].
    Belitskaia GA; Ena IaM; Drannik GN; Varetskaia TV; Tsynkalovskaia SN
    Urol Nefrol (Mosk); 1976; (5):52-5. PubMed ID: 793136
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal disease and fibrinogen degradation products.
    Hedner U; Nilsson IM
    Adv Nephrol Necker Hosp; 1974; 3():241-71. PubMed ID: 4219704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.